<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335842">
  <stage>Registered</stage>
  <submitdate>13/08/2010</submitdate>
  <approvaldate>17/08/2010</approvaldate>
  <actrnumber>ACTRN12610000676011</actrnumber>
  <trial_identification>
    <studytitle>Relationship between prematurity, kidney volume and  retinal micro vasculature among premature babies born in North Queensland</studytitle>
    <scientifictitle>Relationship between prematurity, kidney volume and  retinal micro vasculature</scientifictitle>
    <utrn>U1111-1116-5143</utrn>
    <trialacronym>PremBNQ</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Premature babies</healthcondition>
    <healthcondition>Prematurity and its effect on kidney growth and retinal vasculature development.</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Normal development and function of male and female renal and urogenital system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Complications of newborn</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Premature babies will undergo ultrasound kidneys, eye examination ,blood test for renal function and urine analysis twice ( at 32 weeks corrected age and a  at 38 weeks corrected age). The investigations will take approximately 1 hour on each occasion. The total duration of the study is for 24 months</interventions>
    <comparator>A group of term babies ( born after 37 completed weeks) will undergo  ultrasound kidneys, eye examination ,blood test for renal function and urine analysis  as premature baby but only once . The testing will be done in the first week of life and the duration all the tests would be approximately 1 hour.The total duration of the study is for 24 months</comparator>
    <control>Active</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Kidney volume  will be calculated by measuring the width, thickness and length of the kidney. The  estimated glomerular filtration rate (eGFR ) would be calculated  using serum creatinine and Cystatin C levels.</outcome>
      <timepoint>at 38 weeks corrected age</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Retinal  vessels thickess and tortuosity  would be measured using  semi-automated software (Computer-Aided Image Analysis of the Retina (CAIAR)).</outcome>
      <timepoint>at 38 weeks corrected age</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Premature babies less than 32 weeks of gestation with parental consent would be recruited into this study.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>42</inclusivemaxage>
    <inclusivemaxagetype>Weeks</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Babies with congenital renal, eye and chromosomal abnormalities will be excluded from this study.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Case control</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/09/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>170</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Yogavijayan Kandasamy</primarysponsorname>
    <primarysponsoraddress>Townsville Hospital
100 Angus Smith Drive
Douglas
QLD 4814</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Townsville Hospital Private Practice and Research Grant</fundingname>
      <fundingaddress>100 Angus Smith Drive
Douglas 
QLD 4814</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Dr Roger Smith</othercollaboratorname>
      <othercollaboratoraddress>Mothers and Babies Research Centre
John Hunter Hospital
Locked Bag 1, Hunter Region Mail Centre,  
Newcastle,  NSW  2310</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr Ian Wright</othercollaboratorname>
      <othercollaboratoraddress>Mothers and Babies Research Centre
John Hunter Hospital
Locked Bag 1, Hunter Region Mail Centre,  
Newcastle,  NSW  2310</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The main focus of this study is to look at the effect of prematurity on kidney growth and function . Kidney size and function in a cohort premature babies (&lt; 32 weeks) is compared with control group (term babies).The study also looks at the rate of kidney growth when a baby is born premature .It will also  determine if retinal vasculature ( arterial/venous diameter and branching angles)  has correlation to  kidney size , kidney function , baby's sex and ethnicity. Most literature says that the foetal retinal matures by 36 to 37 weeks gestation . Baby with significant Retiopathy of prematurity (ROP) will be excluded from analysis .</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Townsville Health District Human Research Ethics Committee</ethicname>
      <ethicaddress>100 Angus Smith Drive
Douglas ,Qld 4814</ethicaddress>
      <ethicapprovaldate>11/05/2010</ethicapprovaldate>
      <hrec>HREC/10/QTHS/52</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Yogavijayan Kandasamy</name>
      <address>Townsville Hospital
100 Angus Smith Drive
Douglas
QLD 4814</address>
      <phone>61747961111</phone>
      <fax>61747962981</fax>
      <email>Yoga_Kandasamy@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr  Yogavijayan Kandasamy</name>
      <address>Townsville Hospital
100 Angus Smith Drive
Douglas
QLD 4814</address>
      <phone>61747961111</phone>
      <fax>61747962981</fax>
      <email>Yoga_Kandasamy@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Yogavijayan Kandasamy</name>
      <address>Townsville Hospital
100 Angus Smith Drive
Douglas
QLD 4814</address>
      <phone>61747961111</phone>
      <fax>61747962981</fax>
      <email>Yoga_Kandasamy@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>